CSI Market
Sign In | Register

Integra Lifesciences Holdings (IART) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access IART Annual Cash Flow →
Observing cash flow movements over recent quarters helps explain how Integra Lifesciences Holdings adapts cash usage as operating conditions change.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-0.13
Depreciation & amortization76.57
Amortization of Other Assets54.00
Accretion Expense0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability-0.77
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories3.86
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment-0.73
Share-based Compensation0.90
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Non Cash Interest Expense Cash Flow-
Available For Sale Securities Gross Realized Gain Loss Net-
Amortization Of Debt Issuance Costs And Debt Refinanced Fees1.00
Noncash Or Part Noncash In Process Research And Development-
Increase Decrease In Contract With Customer Liability-0.63
Income taxes0.00
Gain (Loss) on Sale of Investments0.00
Increase (Decrease) in Accounts Receivable-10.60
Increase (Decrease) in Accounts Payable and Accrued Liabilities-34.38
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets29.32
Other Working Capital0.82
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-86.22
Discontinued operations0.00
Net Cash flow from Operating Activities32.61
Investing Activities
Capital Expenditures-27.16
Sale of Capital Items0.00
Proceeds from Maturities, Prepayments and Calls of Short-term Investments0.00
Short-term Investments Acq.0.00
Payments for (Proceeds from) Derivative Instrument, Investing Activities0.00
Proceeds from Working Capital Adjustment-
Proceeds from Payments For Business Acquisitions-
Payments To Acquire In Process Research And Development Milestone-
Payments For Proceeds From Business Acquisitions-
Payments To Acquire In Process Research And Development And Intangible Assets-
Increase (Decrease) in Restricted Cash0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Investments-30.98
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Proceeds from Divestiture of Businesses0.00
Accounts payable0.00
Proceeds from Collection of Notes Receivable0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-58.13
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-0.28
Long-term debt - borrowings75.90
Long-term debt - repayments-60.48
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net-1.59
Other net-6.08
Purchase Of Option Hedge On Convertible Notes-
Payments For Option Index To Issuers Equity-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities7.48
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow5.45
Total Cash Flow-20.63
4 historic quarters locked

Sign in to unlock the full Integra Lifesciences Holdings cash flow history.

Sign In Create Free Account

About Integra Lifesciences Holdings Corp Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000917520-26-000058

Figures are derived from filed reports and may be restated. Historical data is subject to revision.